The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALLAKOS INC | COM | 01671P100 | 153,840 | 18,271 | SH | SOLE | 18,271 | 0 | 0 | ||
ALPS ETF TR | ALERIAN MLP | 00162Q452 | 1,123,065 | 29,500 | SH | SOLE | 29,500 | 0 | 0 | ||
ARCELLX INC | COMMON STOCK | 03940C100 | 1,124,640 | 36,302 | SH | SOLE | 36,302 | 0 | 0 | ||
BRIDGETOWN HOLDINGS LTD | *W EXP 09/30/202 | G1355U121 | 4,671 | 39,773 | SH | SOLE | 39,773 | 0 | 0 | ||
CABALETTA BIO INC | COM | 12674W109 | 783,735 | 84,728 | SH | SOLE | 84,728 | 0 | 0 | ||
COMPASS THERAPEUTICS INC | COM | 20454B104 | 1,062,132 | 211,159 | SH | SOLE | 211,159 | 0 | 0 | ||
ELEVATION ONCOLOGY INC | COM | 28623U101 | 64,800 | 68,324 | SH | SOLE | 68,324 | 0 | 0 | ||
LANVIN GROUP HOLDINGS LIMITE | *W EXP 99/99/999 | G5380J118 | 3,776 | 12,000 | SH | SOLE | 12,000 | 0 | 0 | ||
MOLECULAR TEMPLATES INC | COM | 608550109 | 673,381 | 2,052,991 | SH | SOLE | 2,052,991 | 0 | 0 | ||
NEWAMSTERDAM PHARMA COMPANY | *W EXP 11/22/202 | N62509117 | 17,795 | 21,333 | SH | SOLE | 21,333 | 0 | 0 | ||
REZOLUTE INC | COM NEW | 76200L309 | 2,904,535 | 1,403,157 | SH | SOLE | 1,403,157 | 0 | 0 | ||
SAVARA INC | COM | 805111101 | 10,689,654 | 6,896,551 | SH | SOLE | 6,896,551 | 0 | 0 | ||
SCYNEXIS INC | COM NEW | 811292200 | 2,689,357 | 1,723,947 | SH | SOLE | 1,723,947 | 0 | 0 | ||
SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 6,098,611 | 15,947 | SH | SOLE | 15,947 | 0 | 0 | ||
SPDR SER TR | S&P OILGAS EXP | 78468R556 | 2,377,900 | 17,500 | SH | SOLE | 17,500 | 0 | 0 | ||
VECTIVBIO HLDG AG | ORD SHS | H9060V101 | 1,346,055 | 156,222 | SH | SOLE | 156,222 | 0 | 0 | ||
XERIS BIOPHARMA HOLDINGS INC | COM | 98422E103 | 8,031,907 | 6,039,028 | SH | SOLE | 6,039,028 | 0 | 0 |